DK350083A - Fremgangsmaade til fremstilling af phenylethanolaminer - Google Patents

Fremgangsmaade til fremstilling af phenylethanolaminer Download PDF

Info

Publication number
DK350083A
DK350083A DK350083A DK350083A DK350083A DK 350083 A DK350083 A DK 350083A DK 350083 A DK350083 A DK 350083A DK 350083 A DK350083 A DK 350083A DK 350083 A DK350083 A DK 350083A
Authority
DK
Denmark
Prior art keywords
phenylethanolamines
preparing
preparing phenylethanolamines
Prior art date
Application number
DK350083A
Other languages
English (en)
Other versions
DK350083D0 (da
Inventor
Leo Alig
Marcel Mueller
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK350083D0 publication Critical patent/DK350083D0/da
Publication of DK350083A publication Critical patent/DK350083A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Battery Electrode And Active Subsutance (AREA)
DK350083A 1982-08-10 1983-07-29 Fremgangsmaade til fremstilling af phenylethanolaminer DK350083A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH478782 1982-08-10
CH289783 1983-05-27

Publications (2)

Publication Number Publication Date
DK350083D0 DK350083D0 (da) 1983-07-29
DK350083A true DK350083A (da) 1984-02-11

Family

ID=25691672

Family Applications (1)

Application Number Title Priority Date Filing Date
DK350083A DK350083A (da) 1982-08-10 1983-07-29 Fremgangsmaade til fremstilling af phenylethanolaminer

Country Status (18)

Country Link
US (1) US4585796A (da)
EP (1) EP0101069B1 (da)
AU (1) AU570640B2 (da)
CA (1) CA1258454A (da)
CS (1) CS240972B2 (da)
DE (1) DE3363177D1 (da)
DK (1) DK350083A (da)
ES (1) ES524823A0 (da)
FI (1) FI80030C (da)
HU (1) HU191867B (da)
IE (1) IE55896B1 (da)
IL (1) IL69438A (da)
MC (1) MC1536A1 (da)
NO (1) NO832867L (da)
NZ (1) NZ205132A (da)
PH (1) PH18647A (da)
PT (1) PT77173B (da)
ZW (1) ZW15483A1 (da)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1219865A (en) * 1982-05-14 1987-03-31 Leo Alig Aziridine phenethanolamine derivatives
CA1258454A (en) * 1982-08-10 1989-08-15 Leo Alig Phenethanolamines
US5166218A (en) * 1983-10-19 1992-11-24 Hoffmann-La Roche Inc. Phenoxypropanolamines and pharmaceutical compositions thereof
CA1262729A (en) * 1983-10-19 1989-11-07 Leo Alig Phenoxypropanolamines
GB8415377D0 (en) * 1984-06-15 1984-07-18 Beecham Group Plc Compounds
GB8418472D0 (en) * 1984-07-19 1984-08-22 Beecham Group Plc Compounds
ES8800842A1 (es) * 1985-03-01 1987-12-01 Beecham Group Plc Un procedimiento para preparar una formulacion veterinariamente aceptable de ariletanolaminas promotora del crecimiento.
NZ215753A (en) * 1985-04-16 1989-10-27 Hoffmann La Roche Phenethanolamine derivatives and pharmaceutical compositions
CA1287061C (en) * 1986-06-27 1991-07-30 Roche Holding Ltd. Pyridine ethanolamine derivatives
DE3718638A1 (de) * 1987-06-04 1988-12-22 Thomae Gmbh Dr K Neue phenylethanolamine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
FI892341A (fi) * 1988-06-10 1989-12-11 Hoffmann La Roche Propanolaminderivat.
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6011068A (en) * 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
WO1993004373A1 (en) * 1991-08-23 1993-03-04 Nps Pharmaceuticals, Inc. Calcium receptor active molecules
US5763569A (en) * 1991-08-23 1998-06-09 The Brigham And Women's Hospital, Inc Calcium receptor-active molecules
US5858684A (en) * 1991-08-23 1999-01-12 The Brigham And Women's Hospital, Inc. Method of screening calcium receptor-active molecules
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5688938A (en) * 1991-08-23 1997-11-18 The Brigham & Women's Hospital, Inc. Calcium receptor-active molecules
US5321036A (en) * 1993-02-10 1994-06-14 Bristol-Myers Squibb Company Thiazole and oxazole-based β3 adrenergic receptor agonists
US5962314A (en) * 1993-02-23 1999-10-05 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5563171A (en) * 1993-11-05 1996-10-08 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists
US5578638A (en) * 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
BRPI9509411B8 (pt) 1994-10-21 2021-07-06 Nps Pharma Inc composto modulador de receptor de íon inorgânico e composição farmacêutica
ES2201300T3 (es) * 1996-05-01 2004-03-16 Nps Pharmaceuticals, Inc. Compuestos activos frente a receptores de iones inorganicos.
JP4765627B2 (ja) 2003-09-22 2011-09-07 Msd株式会社 新規ピペリジン誘導体
US7737155B2 (en) 2005-05-17 2010-06-15 Schering Corporation Nitrogen-containing heterocyclic compounds and methods of use thereof
EP2330125A3 (en) 2005-08-11 2012-12-12 Amylin Pharmaceuticals, Inc. Hybrid polypeptides with selectable properties
EP2330124B1 (en) 2005-08-11 2015-02-25 Amylin Pharmaceuticals, LLC Hybrid polypeptides with selectable properties
CN101291662A (zh) 2005-10-21 2008-10-22 诺瓦提斯公司 肾素抑制剂和抗血脂异常剂和/或抗肥胖剂的组合
EP2083831B1 (en) 2006-09-22 2013-12-25 Merck Sharp & Dohme Corp. Method of treatment using fatty acid synthesis inhibitors
US20110071129A1 (en) 2008-06-19 2011-03-24 Makoto Ando Spirodiamine-diaryl ketoxime derivative
EP2350010B1 (en) 2008-10-30 2014-03-26 Merck Sharp & Dohme Corp. Isonicotinamide orexin receptor antagonists
EP2379562A1 (en) 2008-12-16 2011-10-26 Schering Corporation Bicyclic pyranone derivatives as nicotinic acid receptor agonists
EP2379547A1 (en) 2008-12-16 2011-10-26 Schering Corporation Pyridopyrimidine derivatives and methods of use thereof
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
AR088352A1 (es) 2011-10-19 2014-05-28 Merck Sharp & Dohme Antagonistas del receptor de 2-piridiloxi-4-nitrilo orexina
US20140045746A1 (en) 2012-08-02 2014-02-13 Merck Sharp & Dohme Corp. Antidiabetic tricyclic compounds
CN113784943A (zh) 2019-04-29 2021-12-10 埃科莱布美国股份有限公司 含氧氨基酚化合物和防止单体聚合的方法
US12018130B2 (en) 2020-10-21 2024-06-25 Ecolab Usa Inc. Alkoxylated (hydroxyalkyl)aminophenol polymers and methods of use

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD45721A (da) *
GB1109924A (en) * 1965-11-29 1968-04-18 Roche Products Ltd Novel substituted diphenylalkyl amines and a process for the manufacture thereof
GB1200886A (en) * 1966-09-23 1970-08-05 Allen & Hanburys Ltd Phenylaminoethanol derivatives
US3732300A (en) * 1966-09-23 1973-05-08 Allen & Hanburys Ltd Phenylaminoethanol derivatives
US4101579A (en) * 1969-02-06 1978-07-18 Allen & Hanburys Limited Phenethanolamine ethers
DE1922003C3 (de) * 1969-04-30 1979-10-11 Boehringer Mannheim Gmbh, 6800 Mannheim N-(3-Aryloxy-2-hydroxypropyl)-aminocarbonsäuren, deren Ester, Amide und Salze, Verfahren zur Herstellung dieser Verbindungen und deren Verwendung bei der Bekämpfung von Herzinsuffizienz
DE2023829C3 (de) * 1970-05-15 1979-06-21 Pfizer Corp., Colon (Panama) Kernsubstituierte 3-Phenoxy-lphenoxyalkyl-amino-propan-2-oIe, Verfahren zu ihrer Herstellung sowie Arzneimittel
US3867455A (en) * 1970-06-02 1975-02-18 Allen & Hanburys Ltd Preparation of phenylaminoethanols
US4137328A (en) * 1970-07-18 1979-01-30 Pfizer Inc. Phenyl-alkanolamine, alkylamine and α-aminoalkyl ketone derivatives as heart stimulants
GB1394001A (en) * 1972-12-22 1975-05-14 Pfizer Ltd 2-morpholino or homomorpholino 1-3-trifluoromethylphenyl propanes
CA1145766A (en) * 1978-07-03 1983-05-03 Jack Mills Optically active phenethanolamines and method for increasing cardiac contractility
IL57671A (en) * 1978-07-03 1982-11-30 Lilly Co Eli Phenethanolamines,process for their preparation and pharmaceutical and animal feed compositions containing the same
IL57670A (en) * 1978-07-03 1982-11-30 Lilly Co Eli Phenethanolamines,their preparation and pharmaceutical formulations comprising them
EP0023385B1 (en) * 1979-06-16 1982-12-15 Beecham Group Plc Ethanamine derivatives, their preparation and use in pharmaceutical compositions
EP0021636B1 (en) * 1979-06-16 1982-12-01 Beecham Group Plc Secondary amines, their preparation and use in pharmaceutical compositions
EP0025331B1 (en) * 1979-09-06 1983-03-02 Beecham Group Plc Cinnamic acid derivatives, their preparation, and pharmaceutical compositions containing them
EP0028105B1 (en) * 1979-10-25 1983-01-19 Beecham Group Plc Secondary amines, their preparation and use in pharmaceutical compositions
EP0029320B1 (en) * 1979-11-15 1985-07-10 Beecham Group Plc Secondary ethanol amines, their preparation and their use in pharmaceutical compositions
EP0040000B1 (en) * 1980-05-08 1983-10-12 Beecham Group Plc Arylethanolamine derivatives, their preparation and use in pharmaceutical compositions
DE3162756D1 (en) * 1980-05-22 1984-04-26 Beecham Group Plc Arylethanolamine derivatives, their preparation and use in pharmaceutical compositions
GB2084577B (en) * 1980-09-26 1984-05-02 Beecham Group Ltd Secondary amines
DE3264364D1 (en) * 1981-03-06 1985-08-01 Beecham Group Plc Arylethanol amine derivatives, their preparation and use in pharmaceutical compositions
DE3260490D1 (en) * 1981-03-31 1984-09-06 Beecham Group Plc Secondary amines, their preparation, pharmaceutical compositions containing them and their use
EP0063004A1 (en) * 1981-04-09 1982-10-20 Beecham Group Plc Secondary amines, processes for their preparation, and pharmaceutical compositions containing them
EP0068669A1 (en) * 1981-06-20 1983-01-05 Beecham Group Plc Secondary phenylethanol amines, processes for their preparation and their pharmaceutical application
EP0070133B1 (en) * 1981-07-11 1986-05-14 Beecham Group Plc Secondary phenylethanol amines, processes for their preparation and their pharmaceutical application
EP0070134B1 (en) * 1981-07-11 1985-11-13 Beecham Group Plc Secondary phenyl ethanol amines and their pharmaceutical use
CA1219865A (en) * 1982-05-14 1987-03-31 Leo Alig Aziridine phenethanolamine derivatives
CA1258454A (en) * 1982-08-10 1989-08-15 Leo Alig Phenethanolamines

Also Published As

Publication number Publication date
NO832867L (no) 1984-02-13
CS240972B2 (en) 1986-03-13
HU191867B (en) 1987-04-28
IE831872L (en) 1984-02-10
ZW15483A1 (en) 1985-01-30
ES8505333A1 (es) 1985-06-01
DK350083D0 (da) 1983-07-29
PT77173B (en) 1986-03-20
AU570640B2 (en) 1988-03-24
NZ205132A (en) 1987-03-06
PH18647A (en) 1985-08-23
EP0101069B1 (de) 1986-04-23
FI832844A (fi) 1984-02-11
IL69438A (en) 1986-08-31
CA1258454A (en) 1989-08-15
FI80030C (fi) 1990-04-10
EP0101069A1 (de) 1984-02-22
IL69438A0 (en) 1983-11-30
FI80030B (fi) 1989-12-29
US4585796A (en) 1986-04-29
CS586083A2 (en) 1985-06-13
MC1536A1 (fr) 1984-05-25
DE3363177D1 (de) 1986-05-28
AU1758883A (en) 1984-02-16
ES524823A0 (es) 1985-06-01
FI832844A0 (fi) 1983-08-08
PT77173A (en) 1983-09-01
IE55896B1 (en) 1991-02-14

Similar Documents

Publication Publication Date Title
DK350083A (da) Fremgangsmaade til fremstilling af phenylethanolaminer
DK300883D0 (da) Fremgangsmade til fremstilling af thromobolytiske midler
DK49984A (da) Fremgangsmaade til fremstilling af chymosin
DK174383D0 (da) Fremgangsmade til fremstilling af et phenylalkylaminoethylsalicylamid
DK210083A (da) Fremgangsmaade til fremstilling af 6a,10a-trans-hexahydrodibenzopyranoner
DK369583A (da) Fremgangsmaade til fremstilling af methanol
DK582883D0 (da) Fremgangsmaade til fremstilling af modelis
DK479981A (da) Fremgangsmaade til fremstilling af 3-aryl-3-hydroxyphthalimidiner
DK355584A (da) Fremgangsmaade til fremstilling af 3-exomethylen-cephalosporiner
DK424083D0 (da) Fremgangsmade til fremstilling af anthracyclinglycosider
DK40883A (da) Fremgangsmaade til fremstilling af benzothienylallylaminer
DK501582A (da) Fremgangsmaade til fremstilling af acylcyanider
DK105082A (da) Fremgangsmaade til fremstilling af substituerede trifluormethylphenyl-tetrahydropyridiner
DK518883D0 (da) Fremgangsmade til fremstilling af 1-oxa-beta-lactam-forbindelser
DK457983A (da) Fremgangsmaade til fremstilling af beta-lactam
DK446683D0 (da) Fremgangsmade til fremstilling af 6-anilino-5,8-quinoxalindioner
DK219483D0 (da) Fremgangsmade til fremstilling af anthracyclinglycosider
DK385983A (da) Fremgangsmaade til fremstilling af 1-oxacephamer
DK548081A (da) Fremgangsmaade til fremstilling af buspiron
DK212884A (da) Fremgangsmaade til fremstilling af isoxazolylimidazolidinoner
DK432683A (da) Fremgangsmaade til fremstilling af 2-hydroxy-2-phenylethylaminer
DK202983A (da) Fremgangsmaade til fremstilling af l-lysin
DK496183A (da) Fremgangsmaade til fremstilling af nitroalkaner
DK155795C (da) Frengangsmaade til fremstilling af 2-t-butyl-5-chlorpyrimidin
DK137583A (da) Fremgangsmaade til fremstilling af 2-pyridylalkylaminer

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment
AHB Application shelved due to non-payment